| Document |
Document Title |
|
JPH0586957B2 |
|
|
JPH05331132A |
PURPOSE: To provide a new sulfate useful as an intermediate for the synthesis of a sulfamate showing excellent anticonvulsive activity and useful for diseases such as epilepsy glaucoma. CONSTITUTION: The compd. is a chlorosulfate express...
|
|
JPH0578557B2 |
|
|
JPH05507487A |
(57)【要約】 本公報は電子出願前の出願データであるため
要約のデータは記録されません。
|
|
JPH05279378A |
PURPOSE: To provide an efficient process for continuous production of a sucrose 6-ester without requiring the addition or removal of an acid. CONSTITUTION: A soln. of sucrose and trimethyl orthoacetate in dimethylformamide is passed thro...
|
|
JPH0575759B2 |
|
|
JPH0574595B2 |
|
|
JPH05262785A |
PURPOSE: To obtain a mercaptal of an oligosaccharide and more particularly a mercaptal of a disaccharide by reacting the oligosaccharide with thiol in the presence of a halocarboxylic acid. CONSTITUTION: The objective compd. is obtd. by ...
|
|
JPH0567153B2 |
|
|
JPH0565517B2 |
|
|
JPH05230011A |
PURPOSE: To obtain a sulfamate showing antispasmodic activity and useful for the treatment for symptoms such as epilepsy from an easily available source material under safe conditions. CONSTITUTION: A compd. expressed by RCH2OH (R is for...
|
|
JPH0560474B2 |
|
|
JPH05222082A |
PURPOSE: To provide a new staurosporin deriv. which has a significant and selective inhibiting effect against proteinkinase C, and therefore, which is useful as a therapuetic drug for diseases corresponding to proteinkinase C inhibition ...
|
|
JPH05140179A |
PURPOSE: To provide the subject compounds showing an antiviral effect and a cell-proliferation inhibitory effect. CONSTITUTION: Derivatives of formula I (X is H, a lower alkyl, etc.; R1 and R2 are H or an OH-protecting group) and salt th...
|
|
JPH0529369B2 |
|
|
JPH0597886A |
PURPOSE: To provide a new compound useful as a flavorant-releasing additive. CONSTITUTION: The compound of the formula, e.g. 4'-formyl-2'- methoxyphenyl-4,6-O-(α-hexylcinnamylidene)-β-D-glucopyrano
side, is obtained, for example, by mi...
|
|
JPH0523278B2 |
|
|
JPH0532687A |
PURPOSE: To provide the subject new derivative enabling accurate and efficient determination of α-amylase activity and useful as a reagent for the determination of α-amylase activity. CONSTITUTION: The derivative of formula I (X1 is me...
|
|
JPH0525192A |
PURPOSE: To provide a novel β-D-glucose having an antitumor activity, useful as an intermediate for synthesizing a carcinostatic agent: etoposide, and giving the easily purified etoposide in a high purity and a good yield. CONSTITUTION:...
|
|
JPH05500374A |
(57)【要約】 本公報は電子出願前の出願データであるため
要約のデータは記録されません。
|
|
JPH0517492A |
PURPOSE: To obtain a maltooligosaccharide derivative useful as a synthetic intermediate for a ketobutylidene-chloro-nitrophenyl-β-maltopentaoside of a reagent for measuring an α-amylase activity. CONSTITUTION: A maltooligosaccharide de...
|
|
JPH055824B2 |
|
|
JPH05500057A |
(57)【要約】 本公報は電子出願前の出願データであるため
要約のデータは記録されません。
|
|
JPH054985A |
PURPOSE: To obtain a novel compd. useful as an anti-carcinoma agent. CONSTITUTION: A compd. of the formula (Y is H, deuterium, A is H, deuterium, a 1 to 4 C alkyl, etc.; X1, X2 together with C to which both are bonded form a cyclic aceta...
|
|
JPH0481597B2 |
|
|
JPH0471919B2 |
|
|
JPH0471079B2 |
|
|
JPH04321696A |
PURPOSE: To obtain the title compound to be used e.g. as an intermediate for synthesizing antineoplastically active substances without substrate degradation, by reaction in an aprotic solvent, between 2-deoxyamino sugar and a halogenodic...
|
|
JPH0466874B2 |
|
|
JPH04154761A |
NEW MATERIAL:A compound expressed by formula I [A is formula II or III (B is O, S or substitutable CH2; R5 is H or protecting Group of OH; R6 is H, alkoxy, OH, protected OH, alkylthio, halogen or, together with H of CH2, forms single bon...
|
|
JPH0425272B2 |
|
|
JPH0459789A |
NEW MATERIAL:The cyclonucleosides expressed by formula I (R1 is H, NH2 or OH; R3 is H or NH2). EXAMPLE: 8,3'-S-cyclo-2',3'-dideoxyadenosine. USE: An antiviral agent stable to acid and useful as a remedy for viral diseases such as AIDS. P...
|
|
JPH0426696A |
NEW MATERIAL:A compound of formula I (R1-R4 are each H or hydroxyl; R5 and R6 are such that one of them is H, the other being group of formula II, etc.) or formula III(R7-R10 are each H or hydroxyl; R11 and R12 are such that one of them ...
|
|
JPH0418072A |
PURPOSE: To effectively prepare the subject compound, by converting 1,2-O- isopropylidene-5-oxo-α-D-glucuronolactone hydrate into its oxime, catalytically hydrogenating the same, reducing the product by a hydride reducing agent, and rea...
|
|
JPH03261795A |
NEW MATERIAL:A compound expressed by formula I (R1 is H, alkyl, aryl or substituent group containing a functional group; R2 and R3 are H, alkyl or aryl; R4 and R5 are H, halogen, alkyl, aryl, alkoxycarbonyl or protected hydroxymethyl; x ...
|
|
JPH03261772A |
NEW MATERIAL:A compound of formula I (n is 2-4). EXAMPLE: 2(RS)-5,5-Dimethyl-D-galacto-(1',2',3',4',5'-pentahydroxypen
tyl) thiazohidine-4-(S)-carboxylic acid. USE: A glycation-inhibiting agent. Useful for treating arterial sclerosis acc...
|
|
JPH0372626B2 |
|
|
JPH03251595A |
NEW MATERIAL:A compound of formula I (Ac is acetyl). USE: A deoxyribonucleic acid(DNA) transoription-controlling agent. PREPARATION: A compound of formula II (Bn is benzyl; Z is benzyloxycarbonyl) is glycosylated using a compound of form...
|
|
JPH03236395A |
NEW MATERIAL:A compound expressed by formula I [R1 is formula II, -(CH2)m (m is 1-5) or formula III (n is 1-10); R2 is H or CH3; X is reducing sugar residue, sulfuric acid ester thereof or alkali salt of the ester residue]. USE: A produc...
|
|
JPH0366314B2 |
|
|
JPH03218390A |
NEW MATERIAL: A compound of formula I [R1 is H or 1-6C alkyl; R is Ar or Ar1; Ar is 3-ethoxy-4-hydroxyphenyl or 5-methylthiophen-2-yl; Ar1 is formula II (A is phenyl and R2 is 1-6C alkyl, A is 4-methoxyphenyl and R2 is H or 1-6C alkyl, o...
|
|
JPH03215492A |
NEW MATERIAL:A compound expressed by formula I (one of A1 and A2 is H and the other is OH; G is derivative of sugar or sugar excluding glucose). EXAMPLE: A compound expressed by formula II. USE: Used as a substrate for determination of N...
|
|
JPH03209393A |
PURPOSE: To obtain the subject compound having an antiviral activity and especially useful for AIDS by reacting a specific compound with an organic halogenocompound, treating the reaction product with a diester of an azodicarboxylic acid...
|
|
JPH0350747B2 |
|
|
JPH03163091A |
NEW MATERIAL: Compounds of the formula (R1 is H, C4-11 alkoxyl, hydroxyl residue, aralkyl having at least 7C, etc.; R2 is H, C4-7 alkoxy, methylthiocarbonyl, etc.; R3 is H, halogen alkylene, aralkyl having at least 7C, etc.). EXAMPLE: 1,...
|
|
JPH03153696A |
NEW MATERIAL:A compound expressed by formula I or II (R is H or Ac). USE: Useful for synthesizing lactose derivatives such as N-acetyllactosamine. PREPARATION: 1,6-Anhydrolactose and 1,1-dimethoxycyclohexane in a molar amount of 2-9 time...
|
|
JPH03145463A |
PURPOSE: To obtain nojirimycin-δ-lactam and deoxynojirimycin by using an epoxide derivative of L-idofranoise as a branch intermediate. CONSTITUTION: A pyridine ring is formed by connecting N between C-1 and C-5, in accompany with the re...
|
|
JPH0325437B2 |
|
|
JPH0363224A |
NEW MATERIAL:A compound expressed by formula I (R1 is H or benzoyl; R2 is alkyl). EXAMPLE: Methyl-4,6-O-(3',4'-dibenzoyloxybenzylidene)-α-D-glucopyran
oside. USE: Antiphlogistics for treating chronic rheumatism. The compound expressed b...
|
|
JPH0347193A |
NEW MATERIAL:A compound expressed by formula I [one to four of R1 to R8 are 1-40C aliphatic acyl groups and the rest are H; when one is the aliphatic acyl group, it is not 2-palmitoyl or 6-aliphatic acyl group; when two are aliphatic acy...
|
